ArticleCancer & metabolism2026

Normoxic HIFα-mediated metabolic rewiring in cancer as a novel therapeutic target of tumor heterogeneity.

Anaís Sánchez-Castillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.